Chlorthalidone Dissolution Failure Recall
Inventia Healthcare Voluntarily Recalls Over 13,000 Bottles of Chlorthalidone Nationwide
Anonymous
Inventia Healthcare is voluntarily recalling 13,567 bottles of 25 mg chlorthalidone nationwide after the tablets failed dissolution testing, which may affect how much medication is absorbed. The recall covers 100-tablet bottles from batch RISA24002, with an April 2027 expiration date; the company initiated it on September 3, and the FDA classified it as Class II on September 17. Class II means use could cause temporary or medically reversible health effects, while the likelihood of serious harm is considered remote. The recall remains ongoing, and the company issued a similar recall in June involving 11,460 bottles after another dissolution failure. Patients should check their bottle’s batch number and contact their pharmacist or prescriber if it is affected; they should not change or stop prescribed treatment without medical advice.
Key Points
1
The affected bottles are identified by NDC 64980-599-01, and the FDA recall number is D-0852-2026.
2
The medication was distributed by Rising Pharma Holdings Inc., based in New Jersey.
3
Patients and health care providers can report adverse events related to the recalled product to the FDA’s MedWatch program at 1-800-FDA-1088.
4
Chlorthalidone is a diuretic used to treat high blood pressure and may also be prescribed to reduce swelling associated with heart, kidney or liver disease.
Sentiment
Mostly NegativeNEGATIVENEUTRALPOSITIVE
Publishers
20
Articles
119
Reach
139
Topics
A
AnonymousAuthor
